Stratrix
On the Record · Keenova Therapeutics

Keenova Therapeutics subsidiaries, as it lists them

The subsidiaries Keenova Therapeutics lists in its latest annual report, with the jurisdiction of each, linked to the filing.

Subsidiaries it lists

SubsidiaryJurisdiction
BP USA Holdings, LLCUnited States
Cache Holdings LimitedBermuda
Carnforth LimitedBermuda
CPEC, LLCUnited States
EFHI GP LimitedIreland
ELP 2025 GP LimitedIreland
Endo Biologics LimitedIreland
Endo Enterprise, Inc.United States
Endo Finance Holdings LPUnited States
Endo LPUnited States
Endo Operations LimitedIreland
Endo USA, Inc.United States
Ikaria Australia Pty LtdAustralia
Ikaria Canada Inc.Canada
Infacare Pharmaceutical CorporationUnited States
INO Therapeutics LLCUnited States
Keenova International Holdings LLCUnited States
Keenova Therapeutics Group LimitedIreland
Keenova Therapeutics Public Limited CompanyIreland
KT Finance Inc.United States
Ludlow LLCUnited States
MAK LLCUnited States
Mallinckrodt ARD Holdings Inc.United States
Mallinckrodt ARD Holdings LimitedUnited Kingdom
Mallinckrodt ARD LLCUnited States
Mallinckrodt Brand Pharmaceuticals LLCUnited States
Mallinckrodt Canada Cooperatie U.A.Netherlands
Mallinckrodt CB LLCUnited States
Mallinckrodt Critical Care Finance LLCUnited States
Mallinckrodt Equinox Finance LLCUnited States
Mallinckrodt Equinox LimitedUnited Kingdom
Mallinckrodt Finance Management Ireland LimitedIreland
Mallinckrodt Group S.à r.l.Luxembourg
Mallinckrodt Group S.à r.l., Luxembourg (LU) Schaffhausen BranchSwitzerland
Mallinckrodt Holdings GmbHSwitzerland
Mallinckrodt Hospital Products Inc.United States
Mallinckrodt International Finance SALuxembourg
Mallinckrodt International Holdings S.à r.l.Luxembourg
Mallinckrodt Lux IP S.à r.l.Luxembourg
Mallinckrodt Manufacturing LLCUnited States
Mallinckrodt Medical Holdings (UK) LimitedUnited Kingdom
Mallinckrodt Medical Holdings (UK) Limited, Zweigniederlassung Deutschland (the German Branch)Germany
Mallinckrodt Petten Holdings B.V.Netherlands
Mallinckrodt Pharma IP Trading LimitedIreland
Mallinckrodt Pharma K.K.Japan
Mallinckrodt Pharmaceuticals Ireland LimitedIreland
Mallinckrodt Pharmaceuticals LimitedUnited Kingdom
Mallinckrodt Quincy S.à r.l.Luxembourg
Mallinckrodt SAG Holdings GmbHSwitzerland
Mallinckrodt UK Finance LLPUnited Kingdom
Mallinckrodt UK LtdUnited Kingdom
Mallinckrodt US Pool LLCUnited States
Mallinckrodt Windsor S.à r.l.Luxembourg
MCCH LLCUnited States
MHP Finance LLCUnited States
MNK 2011 LLCUnited States
Montjeu LimitedIreland
OCERA Therapeutics LLCUnited States
Operand Pharmaceuticals Holdco I Unlimited CompanyIreland
Paladin Pharma Inc.Canada
Petten Holdings Inc.United States
Profibrix B.V.Netherlands
Questcor International LimitedIreland
Salvare Merger Sub LLCUnited States
Sonorant Therapeutics LimitedIreland
ST Operations LLCUnited States
ST Shared Services LLCUnited States
ST US AR Finance LLCUnited States
ST US Holdings LLCUnited States
ST US Pool LLCUnited States
Stratatech CorporationUnited States
Sucampo Finance Inc.United States
Sucampo GmbHSwitzerland
Sucampo Holdings Inc.United States
Sucampo International Holdings LimitedUnited Kingdom
Sucampo Pharma Americas LLCUnited States
Sucampo Pharma, LLCJapan
Sucampo Pharmaceuticals LLCUnited States
Vtesse LLCUnited States

From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.

Read from Keenova Therapeutics’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-04-15. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.